Modern Diagnostic & Research Centre Limited announced the approval of its unaudited financial results for the half-year ended September 30, 2026. The Board of Directors also reviewed the Limited Review Report and considered a proposal for the takeover or acquisition of a diagnostic centre. The company’s net profit for the period stood at ₹62.38 lakhs.
Financial Results and Board Approvals
Modern Diagnostic & Research Centre Limited convened a Board meeting on November 14, 2026, to consider and approve key financial and strategic matters. The Board formally approved the unaudited financial results for the half-year ended September 30, 2026, along with the accompanying Limited Review Report from M/s Gupta Iyer & Co, Chartered Accountants. The company reported a profit of ₹62.38 lakhs for the period.
Strategic Considerations
In addition to the financial review, the Board also considered a significant proposal for the takeover or acquisition of a diagnostic centre that possesses imaging facilities. This strategic consideration indicates a potential expansion or consolidation move for Modern Diagnostic & Research Centre Limited. The details of this proposal were not elaborated upon in the disclosure.
Key Financial Highlights (Half Year Ended September 30, 2026)
Statement of Financial Results
The unaudited financial results for the half-year ended September 30, 2026, presented the following key figures:
- Revenue from operations (net): ₹4387.43 lakhs
- Other Income: ₹10.16 lakhs
- Total Income: ₹4397.59 lakhs
- Total Expenses: ₹4337.76 lakhs
- Profit before exceptional and extraordinary item and tax: ₹59.83 lakhs
- Profit before Tax: ₹59.83 lakhs
- Tax Expense: ₹3.78 lakhs
- Profit/(Loss) for the Period: ₹62.38 lakhs
- Earning per equity share (Basic): ₹0.41
Statement of Assets and Liabilities (as at September 30, 2026)
The company’s balance sheet as of September 30, 2026, showed:
- Total Equity and Liabilities: ₹11086.75 lakhs
- Total Assets: ₹11086.75 lakhs
Cash Flow Statement (Half Year Ended September 30, 2026)
The cash flow statement indicated:
- Net cash flow from/(used in) operating activities (A): ₹768.24 lakhs
- Net cash used for investing activities (B): ₹42.94 lakhs
- Net cash from financing activities (C): -₹1151.04 lakhs
- Net increase/(decrease) in cash: -₹339.86 lakhs
- Cash & cash equivalent at the end of year: ₹600.14 lakhs
The Board resolution authorizing directors to sign the financial results was also certified as a true copy.
Source: BSE
